Real-Time Biopsies Reveal Hidden Insights into Glioblastoma Therapy Response

October 08, 2025
In a groundbreaking advancement for glioblastoma research, scientists from Break Through Cancer’s Accelerating Glioblastoma Therapies Through Serial Biopsies TeamLab have demonstrated that the oncolytic virus therapy, CAN-3110, sparks a profound and previously undetectable immune response deep within recurrent glioblastoma tumors.

Read More at Bioengineer.org

UPDATES AND NEWS

News

Experimental Glioblastoma Trial Findings Could Lead to Change in Patient Monitoring and Therapy | GEN

News

Serial Biopsies Reveal Immune Activation During Treatment for Recurrent Glioblastoma | Gene Online

Press Release

Real-Time Biopsies Uncover Hidden Response to Glioblastoma Therapy

News

Break Through Cancer launches a $15M multi-institute pediatric osteosarcoma research initiative | The Cancer Letter

View All

BE PART OF THE MISSION
Stay Informed, Make an Impact

Subscribe

Be the first to hear about cutting-edge research, pioneering projects, and the latest advancements in Break Through Cancer science. Sign up to stay informed.

* indicates required
Email Format

Give

Your contribution fuels groundbreaking research in some of the most challenging cancers. Every gift accelerates progress. For more information please contact Michaela Forand at MF@breakthroughcancer.org or 1-800-757-9881 ext 2.

News
6 likes